Publication Date:
2013-09-20
Description:
The HDAC inhibitor, MPT0E028, enhances erlotinib-induced cell death in EGFR-TKI-resistant NSCLC cells Cell Death and Disease 4, e810 (September 2013). doi:10.1038/cddis.2013.330 Authors: M-C Chen, C-H Chen, J-C Wang, A-C Tsai, J-P Liou, S-L Pan & C-M Teng
Keywords:
lung cancerHDACsynergisticEGFRapoptosiserlotinib
Electronic ISSN:
2041-4889
Topics:
Biology
,
Medicine
Permalink